Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

Real-time release testing (RTRT) for TOC and conductivity, microfluidic technology for bacterial endotoxins testing (BET), and rapid microbiological methods (RMMs) for bioburden are all ways in which ...